Market capitalization | $150.29m |
Enterprise Value | $157.02m |
P/E (TTM) P/E ratio | 30.13 |
EV/FCF (TTM) EV/FCF | 24.50 |
EV/Sales (TTM) EV/Sales | 2.76 |
P/S ratio (TTM) P/S ratio | 2.65 |
P/B ratio (TTM) P/B ratio | 4.92 |
Revenue growth (TTM) Revenue growth | 21.01% |
Revenue (TTM) Revenue | $56.80m |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
1 Analyst has issued a forecast Pro-Dex, Inc.:
1 Analyst has issued a forecast Pro-Dex, Inc.:
Sep '24 |
+/-
%
|
||
Revenue | 57 57 |
21%
21%
|
|
Gross Profit | 16 16 |
20%
20%
|
|
EBITDA | 9.53 9.53 |
26%
26%
|
EBIT (Operating Income) EBIT | 8.35 8.35 |
26%
26%
|
Net Profit | 5.21 5.21 |
3%
3%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Pro-Dex, Inc. engages in the design, development, and manufacture of rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. It specializes in medical device and services, industrial and scientific, dental and component, repairs, and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding, and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.
Head office | United States |
CEO | Richard Kirk |
Employees | 148 |
Founded | 1994 |
Website | www.pro-dex.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.